Skip to content
‹ Back to IndustriesSciences

Mirroring the Blue Eel: Non-living Systems Manifest Living Neural Behaviors

Exciting new U.S. Army-funded research inspired by the naturally elegant motion of the swimming blue eel has the potential to answer questions regarding the discrepancy between the movement in living versus non-living systems. These answers can lead to the creation of synthetic materials that simulate natural ones.   Examining the possibilities, a research team lead by…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · ·
Share
Mirroring the Blue Eel: Non-living Systems Manifest Living Neural Behaviors

Key takeaways

01

Army-funded research inspired by the naturally elegant motion of the swimming blue eel has the potential to answer questions regarding the discrepancy between the movement in living versus non-living systems.

02

These answers can lead to the creation of synthetic materials that simulate natural ones.

03

Examining the possibilities, a research team lead by…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Exciting new U.S. Army-funded research inspired by the naturally elegant motion of the swimming blue eel has the potential to answer questions regarding the discrepancy between the movement in living versus non-living systems. These answers can lead to the creation of synthetic materials that simulate natural ones.

Examining the possibilities, a research team lead by Professor of Physics Dr. Seth Fraden of Brandeis University studied how a particular neural network present in the eel produces waves of chemical pulses that propagate down the eel’s spine to rhythmically drive swimming muscles.

In an effort to mimic the eel’s natural neural processes, the team first built a control device that produced the same neural patterns but runs on chemical power as opposed to the hallmark electrical power of hard robotic technology.

After a breakthrough realization that the same CPG dynamics could be simulated on a non-biological platform using the Belousov-Zhabotinsky reaction, a well-known process in the scientific community, they developed techniques to fabricate a diversity of life-like patterns in non-living soft materials. Their chemical configuration eventually created patterns exactly like those of the blue eel.

Fraden’s team objective is to take this new technology and extend it so artificial material can mimic neural tissue as well as neuromuscular tissue.

A valuable resource, the Army Research Office (ARO) funds research to find technological discoveries in extramural organizations, educational institutions, nonprofit organizations and private industry that may make future American Soldiers stronger and safer. 

Read more here

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Verdel's Q-2DMS aims to bring 2D mass spectrometry to more common hardware

Verdel's Q-2DMS aims to bring 2D mass spectrometry to more common hardware

Verdel and Warwick have developed a version of two-dimensional mass spectrometry called Q-2DMS. Until now, only the best-funded centers could afford 2DMS hardware, and Verdel's chief executive argues that the field lacked access, not an understanding of what the method can do. If 2DMS moves onto more common hardware, more labs could evaluate it. Published results show up to tenfold more usable spectral information on closely related or near-isobaric compounds, the look-alike molecules that separation and filtering tend to blur together or drop.

  • 01The reported gain of up to tenfold more usable spectral information applies to closely related or near-isobaric compounds, so the best trial samples are the mixtures chromatography struggles to separate.
  • 02A complete time-stamped record can be revisited after a sample runs out or degrades, and a full acquisition could, in principle, let archived runs address new questions later.

Oct 9, 2026

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512